{4-[4-(2,4-Dichlorophenoxy)-1H-pyrazol-3-yl]-3-hydroxyphenoxy}acetic Acid

ID: ALA5174774

Chembl Id: CHEMBL5174774

PubChem CID: 168277714

Max Phase: Preclinical

Molecular Formula: C17H12Cl2N2O5

Molecular Weight: 395.20

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)COc1ccc(-c2n[nH]cc2Oc2ccc(Cl)cc2Cl)c(O)c1

Standard InChI:  InChI=1S/C17H12Cl2N2O5/c18-9-1-4-14(12(19)5-9)26-15-7-20-21-17(15)11-3-2-10(6-13(11)22)25-8-16(23)24/h1-7,22H,8H2,(H,20,21)(H,23,24)

Standard InChI Key:  GNUIZPWGJHLPGH-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5174774

    ---

Associated Targets(Human)

LPAR1 Tchem Lysophosphatidic acid receptor Edg-2 (779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LPAR2 Tchem Lysophosphatidic acid receptor Edg-4 (418 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LPAR3 Tchem Lysophosphatidic acid receptor Edg-7 (471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 395.20Molecular Weight (Monoisotopic): 394.0123AlogP: 4.34#Rotatable Bonds: 6
Polar Surface Area: 104.67Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.01CX Basic pKa: 1.37CX LogP: 3.90CX LogD: 0.50
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.57Np Likeness Score: -0.94

References

1. Khiar-Fernández N, Zian D, Vázquez-Villa H, Martínez RF, Escobar-Peña A, Foronda-Sainz R, Ray M, Puigdomenech-Poch M, Cincilla G, Sánchez-Martínez M, Kihara Y, Chun J, López-Vales R, López-Rodríguez ML, Ortega-Gutiérrez S..  (2022)  Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice.,  65  (16.0): [PMID:35948083] [10.1021/acs.jmedchem.2c00046]

Source